Strongbridge Biopharma Summary

Strongbridge Biopharma plc (SBBP) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 10 people. Strongbridge Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 254.8 M. Strongbridge Biopharma plc has 39.81 M outstanding shares of which 812.36 K shares are at this time shorted by private and institutional investors with about 5.96 trading days to cover.
Strongbridge Biopharma plc currently holds about 44.37 M in cash with (41.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24.

Strongbridge Biopharma plc, a biopharmaceutical company, focuses on the development, inlicensing, acquisition, and commercialization of various complementary solutions and product candidates that target rare diseases. more

Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.